Hepatitis B is a liver infection caused by the hepatitis B virus (HBV), and long-term hepatitis B infections that last longer ...

CBA therapy of HIV (and possibly other pathogens ... There is a high demand, therefore, for new antiviral lead compounds and novel therapeutic concepts. In this Review, an original therapeutic ...

An immune system defect makes affected individuals vulnerable to severe viral diseases such as influenza or COVID-19. It is ...

Gene therapy, with its offer of a possible cure for rare diseases like sickle cell, is losing early investors to ...

Importantly, for HCV, combination of antiviral drugs with immunomodulatory interferons may eradicate the infection, something that still seems a distant goal for HIV therapy. Although HIV and HCV ...

Preparations are underway for FDA interactions and initiation of Phase 2 studies Data presentation to be provided at the Investor Event on March 31, 2025 at 10:00 AM ET NEWTOWN, Pa., March (GLOBE ...

Emerging data suggest that antiviral therapy in the third trimester can prevent immunoprophylaxis failure. To minimize fetal exposure to antiviral agents, antiviral therapy during pregnancy should ...

Other Late-Breaking Studies Focused on Antiviral Therapies The late-breaking antiviral therapy session also featured new data on long-acting methods of treating patients with virally suppressed HIV.

If you get six or more cold sores per year, your doctor may recommend something called suppressive antiviral therapy, which involves taking an antiviral medication every day to reduce the number ...

It is highly specific, reduces the chances of false positives and once studied further, can also be a target for antiviral therapy against mpox. Read more here. Also Read: US biologists win Nobel ...